Keyword: Loxo


Bayer’s Vitravki Faces Pricing Hurdles

20.01.2020 - Bayer has run into difficulty with healthcare providers in England and Germany over the high cost of the German group’s new “tissue-agnostic” cancer drug Vitrakvi, which was...


Eli Lilly to Buy Loxo for $8 Billion

09.01.2019 - In the latest move by “big pharma” to buy into cancer-focused biotechs, US drugmaker Eli Lilly is acquiring Loxo Oncology for about $8 billion in cash. The plans were announced on...


FDA Greenlights Bayer-Loxo’s Vitrakvi

05.12.2018 - A new type of cancer treatment developed by a partnership of Bayer with biotech partner Loxo Oncology has won approval from the US Food and Drug Administration (FDA). Vitrakvi is...